323P Early safety and efficacy from the phase IIIb TOURMALINE study of durvalumab (D) in combination with gemcitabine (G)-based chemotherapy in advanced biliary tract cancer (aBTC)
Title:
323P Early safety and efficacy from the phase IIIb TOURMALINE study of durvalumab (D) in combination with gemcitabine (G)-based chemotherapy in advanced biliary tract cancer (aBTC)
Author:
Oh, D-Y. Ikeda, M. Mercade, T. Macarulla He, A.R. Park, J.O. Kitano, M. Lamarca, A. Tai, D.W.M. Dayyani, F. Pressiani, T. Wetherill, G. Stell, A. Sun, P. Baur, B. Vogel, A.